Current NDC auxiliary source row compounder:4607

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 72682-8742
Product Ndc: 72682-8742
Product Ndc Digits: 726828742
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Testosterone Cypionate 200mg/ml 5mL
Proprietary Name Suffix: [empty]
Nonproprietary Name: Testosterone Cypionate 200mg/ml 5mL
Dosage Form Name: INJECTION
Route Name: INTRAMUSCULAR; SUBCUTANEOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: AnazaoHealth Corporation
Establishment Name: AnazaoHealth Corporation
Establishment Fei: [empty]
Substance Name: TESTOSTERONE CYPIONATE
Active Ingredients Info: 200 mg/1 mL
History Active Ingredients Raw: TESTOSTERONE CYPIONATE
History Active Ingredients Info Raw: 200 mg/1 mL
History Dosage Raw: INJECTION
Dea Schedule: CIII
Package Ndc Raw: 72682-8742-1
Package Ndc: 72682-8742-1
Package Ndc Digits: 7268287421
Package Ndc11: 72682874201
Package Description: 5 mL in 1 VIAL (72682-8742-1)
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:4607
Source Row Number: 4607
Source Row Hash: 4c04a1369e6c683b689e7c1715e00b1a1a6ec8481a78871e72340a9d08155a14
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR; SUBCUTANEOUS",
    "PRODUCTNDC": "72682-8742",
    "DEASCHEDULE": "CIII",
    "LABELERNAME": "AnazaoHealth Corporation",
    "SUBSTANCENAME": "TESTOSTERONE CYPIONATE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "72682-8742-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Testosterone Cypionate 200mg/ml 5mL",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "Testosterone Cypionate 200mg/ml 5mL",
    "PACKAGEDESCRIPTION": "5 mL in 1 VIAL (72682-8742-1) ",
    "ACTIVEINGREDIENTSINFO": "200 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:4607
Source Row Number: 4607
Status Scope: package
Lookup Ndc: 72682-8742-1
Lookup Ndc Digits: 7268287421
Product Ndc: 72682-8742
Product Ndc Digits: 726828742
Package Ndc: 72682-8742-1
Package Ndc Digits: 7268287421
Package Ndc11: 72682874201
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 4c04a1369e6c683b689e7c1715e00b1a1a6ec8481a78871e72340a9d08155a14
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33